At the Milken Global Conference 2025, Dr. Karen E. Knudsen, CEO of the Parker Institute for Cancer Immunotherapy (PICI), shares her vision for advancing cancer research through immune-based scientific breakthroughs. With a unique model that unites research institutions, biotech, and venture capital, Dr. Knudsen is driving faster pathways from the lab to the clinic to the marketplace.

With three decades of executive leadership across academia, industry, and the nonprofit sector, Dr. Knudsen has built high-impact organisations that translate innovation into tangible patient outcomes and healthcare transformation. She previously served as CEO of the American Cancer Society and now sits on multiple boards, including AstraZeneca, Paradigm Health, Exai Bio, and Research!America.

A nationally recognised healthcare strategist, she highlights the importance of public-private partnerships, translational science, and sustainable healthcare solutions in shaping the future of medicine.

Ian Khan is a globally recognised emerging tech leadership expert. A practising Futurist, Creator of the Future Readiness Leaders Circle, Multiple times author including "Metaverse for Dummies", Filmmaker and Storyteller on PrimeVideo and Emirates Airlines, one of the worlds largest airlines with 10 Million passengers per year. Ian's ground breaking work has been featured on CNN, the BBC, Fox, Bloomberg, Wharton Daily, ArabNews, RT, CoinBase, Korea Times, Spanish Daily Expansión, Ian hosts the worlds largest Future Readiness leadership networks, bringing together high performance entrepreneurs and leaders on a common mission to build future ready and undisputable businesses. Khan's new book is titled "Undisruptable" and is scheduled to release in early 2024.

Visit Ian at www.IanKhan.com